ProQR Therapeutics N.V.
PRQR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612940
In the last 90 days, ProQR Therapeutics N.V. insiders filed 5 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in ProQR Therapeutics N.V. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +1 vs. Q3 2023
- Shares held
- 18.4M
- −324.8K (−1.7%) vs. Q3 2023
- Total value
- $37.0M
- +$12.6M (+51.9%) vs. Q3 2023
- New holders
- 6
- 6 more added
- Sold out
- 5
- 12 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRQR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 70 | $113.0M |
| Q1 2026 | 69 | $56.8M |
| Q4 2025 | 65 | $75.1M |
| Q3 2025 | 64 | $80.0M |
| Q2 2025 | 62 | $82.4M |
| Q1 2025 | 65 | $54.9M |
| Q4 2024 | 77 | $117.7M |
| Q3 2024 | 47 | $31.7M |
| Q2 2024 | 48 | $28.6M |
| Q1 2024 | 49 | $39.8M |
| Q4 2023 | 47 | $37.0M |
| Q3 2023 | 46 | $24.3M |
| Q2 2023 | 51 | $34.2M |
| Q1 2023 | 55 | $47.5M |
| Q4 2022 | 46 | $60.0M |
| Q3 2022 | 47 | $15.9M |
| Q2 2022 | 51 | $17.2M |
| Q1 2022 | 58 | $28.7M |
| Q4 2021 | 74 | $364.8M |
| Q3 2021 | 67 | $333.4M |
| Q2 2021 | 63 | $259.4M |
| Q1 2021 | 64 | $286.4M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding ProQR Therapeutics N.V.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $11.1M | 3.10% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 3,625,467 | $7.18M | 0.01% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 2,980,016 | $5.90M | 0.15% | 00.0% | Unchanged |
| M28 Capital Management LP | 1,910,600 | $3.78M | 3.13% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 940,582 | $1.86M | 0.45% | 00.0% | Unchanged |
| Macquarie Group Ltd | 620,000 | $1.23M | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 472,625 | $935.8K | 0.26% | 00.0% | Unchanged |
| Millennium Management LLC | 449,062 | $889.1K | 0.00% | +29,017+6.9% | Added |
| Deutsche Bank AG | 385,208 | $762.7K | 0.00% | +385,208 | New |
| Monaco Asset Management SAM | 378,476 | $749.4K | 0.29% | +959+0.3% | Added |
| Two Sigma Advisers, LP | 168,700 | $334.0K | 0.00% | −59,500−26.1% | Reduced |
| Franklin Street Advisors Inc | 150,000 | $297.0K | 0.02% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 128,174 | $253.8K | 0.00% | −4,204−3.2% | Reduced |
| Morgan Stanley | 113,711 | $225.1K | 0.00% | −229,247−66.8% | Reduced |
| Two Sigma Investments, LP | 99,491 | $197.0K | 0.00% | −81,253−45.0% | Reduced |
| Boothbay Fund Management, LLC | 95,745 | $189.6K | 0.01% | 00.0% | Unchanged |
| Bank of America Corp | 78,253 | $154.9K | 0.00% | −30,085−27.8% | Reduced |
| Citadel Advisors LLC | 77,816 | $154.1K | 0.00% | +77,816 | New |
| Geode Capital Management, LLC | 46,671 | $92.4K | 0.00% | +10,378+28.6% | Added |
| Virtu Financial LLC | 34,904 | $69.0K | 0.01% | +34,904 | New |
| Bank of Montreal | 30,000 | $66.3K | 0.00% | +30,000 | New |
| Resources Investment Advisors, LLC. | 31,950 | $63.3K | 0.00% | +12,425+63.6% | Added |
| JustInvest LLC | 21,429 | $42.4K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 18,406 | $36.4K | 0.00% | +8,640+88.5% | Added |
| Mariner, LLC | 18,334 | $36.3K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 17,420 | $34.5K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 15,901 | $31.5K | 0.00% | +9,200+137.3% | Added |
| Susquehanna International Group, LLP | 13,967 | $27.7K | 0.00% | −26,643−65.6% | Reduced |
| Atom Investors LP | 13,107 | $26.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 12,811 | $25.4K | 0.00% | −6,650−34.2% | Reduced |
| Wells Fargo & Company | 10,996 | $21.8K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 10,637 | $21.1K | 0.00% | +10,637 | New |
| Marshall Wace, LLP | 10,085 | $20.0K | 0.00% | −47,632−82.5% | Reduced |
| Truist Financial Corp | 10,000 | $19.8K | 0.00% | 00.0% | Unchanged |
| Vontobel Holding Ltd. | 10,000 | $19.8K | 0.00% | 00.0% | Unchanged |
| Csenge Advisory Group | 10,000 | $19.8K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 10,000 | $19.8K | 0.00% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 5,860 | $11.0K | 0.00% | −354−5.7% | Reduced |
| Cutler Group LP | 4,600 | $9.00K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 3,945 | $7.81K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,900 | $7.72K | 0.00% | −6,144−61.2% | Reduced |
| Tower Research Capital LLC (TRC) | 3,536 | $7.00K | 0.00% | +3,536 | New |
| JPMorgan Chase & Co | 1,814 | $3.59K | 0.00% | −145,691−98.8% | Reduced |
| Simplex Trading, LLC | 1,794 | $3.00K | 0.00% | −12,895−87.8% | Reduced |
| PFS Partners, LLC | 1,000 | $1.98K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 33 | $65 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 200 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −189,328−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −74,084−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −20,822−100.0% | Sold out |
| Flaharty Asset Management, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |